Ledger.Open graph →
SEC Form D · Amendment · filed June 1, 2022

Biolinq Inc

Offering
$105.6M
Sold
$77.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Dan Bradbury · San Diego, CADirectorThad Johnson · San Diego, CADirectorNancy Hong · San Diego, CADirectorJared Tangney · San Diego, CAExecRichard Yang · San Diego, CAExec · DirectorMichael H. Jones · EUGENE, ORDirectorLuke V. Strgar · EUGENE, ORDirectorJohn D. Nichols · Palm Beach, FLExecStephen J. Rooney · Queenstown, Q2DirectorTom H. Zelenovic · EUGENE, ORExec · DirectorPeter Travers · Longwood, FLDirectorRichard W. Rosenfield, M.D · Portland, ORExecRobert Garrison Ii · Houston, TXDirectorSteve Goodbarn · Denver, CODirectorElder Granger · Denver, COExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗